SJR: 0.332 SNIP: 0.491 CiteScore™: 0.89
ISSN Print: 1050-6934
Volumes:Volume 28, 2018 Volume 27, 2017 Volume 26, 2016 Volume 25, 2015 Volume 24, 2014 Volume 23, 2013 Volume 22, 2012 Volume 21, 2011 Volume 20, 2010 Volume 19, 2009 Volume 18, 2008 Volume 17, 2007 Volume 16, 2006 Volume 15, 2005 Volume 14, 2004 Volume 13, 2003 Volume 12, 2002 Volume 11, 2001 Volume 10, 2000
Journal of Long-Term Effects of Medical Implants
Abstract of "Drug-Eluting Stents: Some Lessons for the Ethics of Medical Nanotechnology"
George J. Agich
BGeXperience Program, Senior Research Fellow Social Philosophy and Policy Center Bowling Green State University, Bowling Green, OH 43403; and Ohio State University School of Medicine, Columbus, OH 43210
Much of the literature on the ethics of nanotechnology advocates broad ethical principles such as the precautionary principle, the bioethical principles of autonomy, beneficence, nonmaleficence, and justice, or the ethical concept of professional responsibility. Such approaches are thought to shape ethical considerations relevant for the work of nanoscientists and engineers. However, these approaches often lack specificity or practical salience. They fail to provide appropriate or workable normative guidance for defining areas of ethical concern with any precision; hence, they have limited practical ethical utility. This limitation can discourage or lead to superficial or misleading ethical assessment of nanoscience-related ethical concerns, which is a particularly acute problem in the area of medical applications of nanotechnology. A useful nanoethics should alternatively provide models for interdisciplinary critical analyses of the complex range of normative values shaping the development and deployment of nanomedical technologies. But where can such models be found? This paper examines whether the drug-eluting stent (DES), an implantable medical device for the treatment of cardiovascular disease, can provide a model for exploring the technical, ethical, and social value-related aspects nanoengineered implantable medical devices. I argue that due to its hybrid material, mechanical, biochemical, and clinical applications to a complex and serious clinical problem, DES is an apt technological analogue for nanoengineered implantable devices. This paper identifies how DES provides a map for the normative questions that engineers and physicians will encounter in developing nanoscale technologies for implantable medical devices. These normative issues in medical nanotechnology include economic, ethical, regulatory, and policy questions, and concerns about social costs and benefits, as well as issues of patient rights and safety, all of which figure prominently in the case of DES.
|Begell Digital Portal||Begell Digital Library||eBooks||Journals||References & Proceedings||Research Collections|